High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers

Maehle L, Apold J, Paulsen T, Hagen B, Lovslett K, Fiane B, Van Ghelue M, Clark N, Moller P. High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers. Clin Cancer Res 2008; 14(22):7569-7573.